The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-4-Acetyl-3-ethyl-N-(3-[3-(hydroxyamino)-3-oxoprop-1-en-1-yl]phenyl)-5-methyl-1H-pyrrole-2-carboxamide ID: ALA5094795
PubChem CID: 166635550
Max Phase: Preclinical
Molecular Formula: C19H21N3O4
Molecular Weight: 355.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCc1c(C(=O)Nc2cccc(/C=C/C(=O)NO)c2)[nH]c(C)c1C(C)=O
Standard InChI: InChI=1S/C19H21N3O4/c1-4-15-17(12(3)23)11(2)20-18(15)19(25)21-14-7-5-6-13(10-14)8-9-16(24)22-26/h5-10,20,26H,4H2,1-3H3,(H,21,25)(H,22,24)/b9-8+
Standard InChI Key: GVORXNGLOKKWIC-CMDGGOBGSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
14.8212 -3.9367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6224 -3.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6994 -2.9347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9423 -2.6105 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4019 -3.2300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4974 -4.6911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6816 -4.7858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9852 -5.3467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2401 -4.2963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0795 -5.1017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5840 -3.1553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4065 -2.5180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1229 -2.9186 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3972 -1.6968 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.8301 -2.5020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5430 -2.9054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2455 -2.4895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2367 -1.6674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5153 -1.2629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8157 -1.6853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9618 -2.8904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6691 -2.4741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3854 -2.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0927 -2.4587 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8089 -2.8596 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.3942 -3.6963 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
1 6 1 0
6 7 2 0
6 8 1 0
2 9 1 0
9 10 1 0
5 11 1 0
3 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
17 21 1 0
21 22 2 0
22 23 1 0
23 24 1 0
24 25 1 0
23 26 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 355.39Molecular Weight (Monoisotopic): 355.1532AlogP: 2.86#Rotatable Bonds: 6Polar Surface Area: 111.29Molecular Species: NEUTRALHBA: 4HBD: 4#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.55CX Basic pKa: ┄CX LogP: 2.13CX LogD: 2.13Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.28Np Likeness Score: -0.91
References 1. Schäker-Hübner L, Warstat R, Ahlert H, Mishra P, Kraft FB, Schliehe-Diecks J, Schöler A, Borkhardt A, Breit B, Bhatia S, Hügle M, Günther S, Hansen FK.. (2021) 4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug Leads., 64 (19.0): [PMID:34582215 ] [10.1021/acs.jmedchem.1c01119 ]